Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

GE Stock Has Plenty More Upside as It Heads Toward $15

By Chris Lau, InvestorPlace Contributor

GE stock rallied sharply after its latest earnings report. It is not too late to get in on the rebound, when looking at 2020-21 prospects.

5 Great Dividend Stocks for Young Investors

By Chris Lau, InvestorPlace Contributor

Dividend stocks are boring but predictable, but that doesn't mean young investors shouldn't look toward them to buy and hold forever.

What’s Next for Uber Stock After Markets Soured on the Shares?

By Chris Lau, InvestorPlace Contributor

Investors are growing impatient with the quarterly losses posted by UBER and with Uber stock. Can Uber recover?

As Canopy Growth Stock Stalls, Pot Investors Mull What Will Happen Next?

By Chris Lau, InvestorPlace Contributor

Canopy Growth faces plenty of tough problems ahead. So too, do its competitors. When will outsized growth return to CGC?

3 Recovering Healthcare Stocks to Buy That Already Escaped Flu Season

By Chris Lau, InvestorPlace Contributor

Over the past year, healthcare stocks generally lagged as markets rebounded. That's changing though, starting with these three names.

Load More